TMDX

61.70

1.93% 1.17

Handel nachbörslich: 62.00 0.30 +0.49%

Transmedics Group Inc (TMDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMDX? Forum Prognose

Schlusskurs vom Vortag:

$60.53

Offen:

$60

24-Stunden-Volumen:

1.52M

Relative Volume:

0.85

Marktkapitalisierung:

$2.07B

Einnahmen:

$401.09M

Nettoeinkommen (Verlust:

$32.64M

KGV:

-56.09

EPS:

-1.1

Netto-Cashflow:

$-120.51M

1W Leistung:

-3.98%

1M Leistung:

-20.08%

6M Leistung:

-57.15%

1J Leistung:

-20.11%

1-Tages-Spanne:

$59.72

$62.50

1-Wochen-Bereich:

$59.72

$66.44

52-Wochen-Spanne:

$59.72

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Firmenname

Transmedics Group Inc

Sektor

Healthcare (1176)

Branche

Medical Devices (148)

Telefon

(978) 552-0900

Adresse

200 MINUTEMAN ROAD, ANDOVER, MA

Mitarbeiter

584

Twitter

@transmedics

Nächster Verdiensttermin

2024-10-28

Neueste SEC-Einreichungen

TMDX's Discussions on Twitter

Vergleichen Sie TMDX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMDX Transmedics Group Inc	61.70	2.07B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2024-11-22	Herabstufung	Needham	Buy → Hold
2024-10-29	Bestätigt	Needham	Buy
2024-10-29	Bestätigt	Oppenheimer	Outperform
2024-09-24	Eingeleitet	Robert W. Baird	Outperform
2024-08-21	Eingeleitet	Needham	Buy
2024-06-06	Eingeleitet	Cantor Fitzgerald	Overweight
2024-06-04	Eingeleitet	Stephens	Overweight
2024-03-28	Eingeleitet	Piper Sandler	Overweight
2023-07-19	Eingeleitet	Robert W. Baird	Outperform
2022-08-02	Hochstufung	JP Morgan	Neutral → Overweight
2020-10-08	Herabstufung	JP Morgan	Overweight → Neutral
2020-04-07	Eingeleitet	Oppenheimer	Outperform
2019-05-28	Eingeleitet	Canaccord Genuity	Buy
2019-05-28	Eingeleitet	Cowen	Outperform
2019-05-28	Eingeleitet	JP Morgan	Overweight
2019-05-28	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten

Dec 19, 2024

TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat

Dec 19, 2024

Dec 18, 2024

TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.4%Here's Why - MarketBeat

Dec 18, 2024

Geode Capital Management LLC Has $119.94 Million Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Dec 18, 2024

Dec 17, 2024

TransMedics Group (NASDAQ:TMDX) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat

Dec 17, 2024

Dec 16, 2024

TransMedics Stock Plunges 57.5% in Three Months: What's Next? - MSN

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles - Investing.com Canada

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 14, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 13, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts - Investing.com

Dec 13, 2024

TransMedics reports inducement grants under Nasdaq listing rule - Medical Buyer

Dec 13, 2024

Research Analysts Set Expectations for TMDX Q3 Earnings - MarketBeat

Dec 13, 2024

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Kilgore News Herald

Dec 13, 2024

Dec 12, 2024

TransMedics Welcomes New CFO with $1.4M Equity Package; Grants Strategic Inducement Awards - StockTitan

Dec 12, 2024

Q1 EPS Estimate for TransMedics Group Decreased by Analyst - MarketBeat

Dec 12, 2024